Entrada TherapeuticsTRDA
那斯達克 · USD
7.13
-0.49
(-6.43%)
盤中 08/26 10:55 (UTC+8)
08/26 10:55 (UTC+8)
Entrada TherapeuticsTRDA
7.13
-0.49
(-6.43%)
財務數據
損益表
- 0.59
- 0.95
- 0.20
- 0.37
- 0.21
- 0.02
- 0.02
- 0.01
- 0.01
- 0.01
- 41.27
- 60.17
- -79.33
- 91.10
- -45.03
- -90.51
- -17.23
- -19.52
- -32.64
- 2.63
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 898 | 875 | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 | 19,570 | 94,694 | 59,120 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 898 | 875 | 1,299 | 1,614 | 1,950 | 20,558 | 37,398 | 19,570 | 94,694 | 59,120 |
營業費用 | 45,861 | 43,178 | 43,507 | 48,665 | 48,799 | 42,348 | 43,265 | 41,228 | 41,271 | - |
研發費用 | 35,369 | 33,054 | 33,957 | 38,361 | 37,877 | 32,074 | 33,406 | 31,257 | 32,035 | 28,608 |
推銷及管理費用 | 10,492 | 10,124 | 9,550 | 10,304 | 10,922 | 10,274 | 9,859 | 9,971 | 9,236 | 9,399 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -44,963 | -42,303 | -42,208 | -47,051 | -46,849 | -21,790 | -5,867 | -21,658 | 53,423 | 21,113 |
其他收入及費用 | 2,235 | 2,624 | 3,136 | 3,571 | 3,924 | 4,441 | 5,128 | 5,766 | 4,366 | 4,214 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -42,728 | -39,679 | -39,072 | -43,480 | -42,925 | -17,349 | -739 | -15,892 | 57,789 | 25,327 |
所得稅 | 35 | 38 | 92 | 654 | 178 | - | -1,870 | -1,860 | 2,758 | 1,831 |
稅後純益 | -42,763 | -39,717 | -39,164 | -44,134 | -43,103 | -17,349 | 1,131 | -14,032 | 55,031 | 23,496 |
基本每股稅後盈餘(元) | -1.01 | -0.95 | -0.94 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 |
稀釋每股稅後盈餘(元) | -1.01 | -0.95 | -0.94 | -1.06 | -1.05 | -0.42 | -0.04 | -0.51 | 1.55 | 0.68 |
基本平均股數(千股) | 42221.00 | 41836.00 | 41604.00 | 41462.00 | 41338.00 | 41073.00 | 40842.00 | 40629.00 | 34180.00 | 33497.00 |
稀釋平均股數(千股) | 42221.00 | 41836.00 | 41604.00 | 41462.00 | 41338.00 | 41073.00 | 43050.00 | 40629.00 | 35507.00 | 34790.00 |
還原基本每股稅後盈餘(元) | -1.01 | -0.95 | -0.94 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 |
還原稀釋每股稅後盈餘(元) | -1.01 | -0.95 | -0.94 | -1.06 | -1.05 | -0.42 | -0.04 | -0.51 | 1.55 | 0.68 |
還原基本平均股數(千股) | 42,221 | 41,836 | 41,604 | 41,462 | 41,338 | 41,073 | 40,842 | 40,629 | 34,180 | 33,497 |
還原稀釋平均股數(千股) | 42,221 | 41,836 | 41,604 | 41,462 | 41,338 | 41,073 | 43,050 | 40,629 | 35,507 | 34,790 |
EBITDA(千元) | -42,337 | -39,422 | -38,819 | -42,989 | -42,852 | -17,741 | -2,254 | -18,168 | 56,438 | 24,224 |